Cargando…

The Dark Side of Dendritic Cells: Development and Exploitation of Tolerogenic Activity That Favor Tumor Outgrowth and Immune Escape

Dendritic cells (DC) play a central role in the regulation of the immune responses by providing the information needed to decide between tolerance, ignorance, or active responses. For this reason different therapies aim at manipulating DC to obtain the desired response, such as enhanced cell-mediate...

Descripción completa

Detalles Bibliográficos
Autores principales: Seliger, Barbara, Massa, Chiara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3845009/
https://www.ncbi.nlm.nih.gov/pubmed/24348482
http://dx.doi.org/10.3389/fimmu.2013.00419
_version_ 1782293273973358592
author Seliger, Barbara
Massa, Chiara
author_facet Seliger, Barbara
Massa, Chiara
author_sort Seliger, Barbara
collection PubMed
description Dendritic cells (DC) play a central role in the regulation of the immune responses by providing the information needed to decide between tolerance, ignorance, or active responses. For this reason different therapies aim at manipulating DC to obtain the desired response, such as enhanced cell-mediated toxicity against tumor and infected cells or the induction of tolerance in autoimmunity and transplantation. In the last decade studies performed in these settings have started to identify (some) molecules/factors involved in the acquisition of a tolerogenic DC phenotype as well as the underlying mechanisms of their regulatory function on different immune cell populations.
format Online
Article
Text
id pubmed-3845009
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-38450092013-12-13 The Dark Side of Dendritic Cells: Development and Exploitation of Tolerogenic Activity That Favor Tumor Outgrowth and Immune Escape Seliger, Barbara Massa, Chiara Front Immunol Immunology Dendritic cells (DC) play a central role in the regulation of the immune responses by providing the information needed to decide between tolerance, ignorance, or active responses. For this reason different therapies aim at manipulating DC to obtain the desired response, such as enhanced cell-mediated toxicity against tumor and infected cells or the induction of tolerance in autoimmunity and transplantation. In the last decade studies performed in these settings have started to identify (some) molecules/factors involved in the acquisition of a tolerogenic DC phenotype as well as the underlying mechanisms of their regulatory function on different immune cell populations. Frontiers Media S.A. 2013-12-02 /pmc/articles/PMC3845009/ /pubmed/24348482 http://dx.doi.org/10.3389/fimmu.2013.00419 Text en Copyright © 2013 Seliger and Massa. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Seliger, Barbara
Massa, Chiara
The Dark Side of Dendritic Cells: Development and Exploitation of Tolerogenic Activity That Favor Tumor Outgrowth and Immune Escape
title The Dark Side of Dendritic Cells: Development and Exploitation of Tolerogenic Activity That Favor Tumor Outgrowth and Immune Escape
title_full The Dark Side of Dendritic Cells: Development and Exploitation of Tolerogenic Activity That Favor Tumor Outgrowth and Immune Escape
title_fullStr The Dark Side of Dendritic Cells: Development and Exploitation of Tolerogenic Activity That Favor Tumor Outgrowth and Immune Escape
title_full_unstemmed The Dark Side of Dendritic Cells: Development and Exploitation of Tolerogenic Activity That Favor Tumor Outgrowth and Immune Escape
title_short The Dark Side of Dendritic Cells: Development and Exploitation of Tolerogenic Activity That Favor Tumor Outgrowth and Immune Escape
title_sort dark side of dendritic cells: development and exploitation of tolerogenic activity that favor tumor outgrowth and immune escape
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3845009/
https://www.ncbi.nlm.nih.gov/pubmed/24348482
http://dx.doi.org/10.3389/fimmu.2013.00419
work_keys_str_mv AT seligerbarbara thedarksideofdendriticcellsdevelopmentandexploitationoftolerogenicactivitythatfavortumoroutgrowthandimmuneescape
AT massachiara thedarksideofdendriticcellsdevelopmentandexploitationoftolerogenicactivitythatfavortumoroutgrowthandimmuneescape
AT seligerbarbara darksideofdendriticcellsdevelopmentandexploitationoftolerogenicactivitythatfavortumoroutgrowthandimmuneescape
AT massachiara darksideofdendriticcellsdevelopmentandexploitationoftolerogenicactivitythatfavortumoroutgrowthandimmuneescape